About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of SPARC1103 in Subjects With Spasticity

Study of SPARC1103 in Subjects With Spasticity

NCT02027025·23 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sun Pharma Advanced Research Company Limited

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men and women greater than or equal to 18 years of age
Willing to sign the informed consent form
Women of child bearing potential willing to practice an acceptable method of birth control
Known history of spasticity due to MS

You may not be if

Administration of an investigational drug or device within 30 days prior to Screening Visit 1
Unable to comply with trial procedures in the opinion of the Investigator
Concomitant neurologic conditions causing spasticity
Any medical condition, including psychiatric disease or epilepsy, which would interfere with the interpretation of the trial results

The record

StatusCompleted

PhasePhase 2

Taking part142

StartedApr 2014

UpdatedMay 3, 2019

Conditions

Where23

SPARC Site 4
Long Beach, California, United States
SPARC Site 6
San Diego, California, United States
SPARC Site 10
Aurora, Colorado, United States